Aydin, PelinUzuncakmak, Sevgi KarabulutTor, Ibrahim HakkiBilen, ArzuOzden, Ayse2024-10-042024-10-0420221308-8742https://doi.org/10.5152/eurasianjmed.2022.22128https://search.trdizin.gov.tr/tr/yayin/detay/530194http://hdl.handle.net/20.500.12403/3106Objective: In the present study, the relationship between a poor prognosis and adropin levels in diabetic patients with coronavirus disease 2019 was investigated by measuring serum adropin levels and levels of D-dimer, C-reactive protein, and ferritin, which are considered prognostic factors for coronavirus disease 2019. Materials and Methods: Hundred volunteer participants treated in the Erzurum Regional Training and Research Hospital were included in this study. Serum adropin levels were measured by enzyme-linked immunosorbent assay. The relationship between serum adropin level and C-reactive protein, ferritin, and D-dimer levels was analyzed by correlation analysis. Results: The participants' serum adropin levels differed between the groups (P=.0007). The control group had the highest adropin levels among groups. The lowest adropin levels were in the COVID + diabetes mellitus group. Adropin levels of diabetes mellitus, COVID, and diabetes mellitus + COVID groups were significantly decreased when compared to the control (P<.05). There was a significant negative correlation between adropin and C-reactive protein, D-dimer, and ferritin. Conclusion: Adropin can be used as an auxiliary biomarker, a prognostic factor in the early management of coronavirus disease 2019 patients with diabetes mellitus. We think that our study will guide future studies conducted in this field.eninfo:eu-repo/semantics/openAccessAdropinCOVID-19DMd-dimerCRPArticle54219720110.5152/eurasianjmed.2022.22128357035302-s2.0-85131783012Q3530194WOS:000810387100016N/A